Buy & Sell IDEXX Laboratories, Inc. (IDXX) – IDEXX Laboratories, Inc. Price Today
Aura AI Summary
Key Stats
- $44.34BMarket Cap
- HealthSector
- -10.67%3M Drawdown
- $45.24BEnterprise Value
- -Dividend Yield
- 44 daysTypical Hold Time
IDEXX Laboratories, Inc. (IDXX) is currently valued at a market capitalization of $44.34B, with an enterprise value of $45.24B. Over the past 52 weeks, IDEXX Laboratories, Inc. has traded between a low of $514.61 and a high of $766.68, highlighting its annual price range. Over the past three months, IDEXX Laboratories, Inc. has recorded a drawdown of -10.67%, reflecting recent price volatility. On average, investors hold IDEXX Laboratories, Inc. for approximately 44 days, indicating typical investor behavior on the platform.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Most Recent News
Austria's iShares MSCI ETF offers yield but faces dividend cuts amid slowing bank earnings and ECB easing.
The iShares MSCI Austria ETF (EWO) has gained 55% in a year, driven by price gains and dividend income mainly from Austrian banks like Erste Group. However, its dividend payments have recently declined due to slowing bank earnings amid a slowing euro...
Nobel laureate John Jumper leaves DeepMind to join AI rival Anthropic
John Jumper, a Nobel Prize-winning scientist known for leading DeepMind's AlphaFold team, announced his departure from DeepMind after nearly nine years to join Anthropic, a competing AI company. Jumper's work on AlphaFold, which predicts protein stru...
SpaceX shares cool after IPO surge but index inclusion could boost demand again
SpaceX's stock surged 67% above its IPO price shortly after debut but has since cooled to a 33% gain. The initial excitement is fading, yet the company is expected to be added to stock indexes soon. This inclusion could attract a new wave of investor...
